Daniël M. Jonker

1.1k total citations
19 papers, 890 citations indexed

About

Daniël M. Jonker is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Daniël M. Jonker has authored 19 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Psychiatry and Mental health. Recurrent topics in Daniël M. Jonker's work include Epilepsy research and treatment (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and Statistical Methods in Clinical Trials (4 papers). Daniël M. Jonker is often cited by papers focused on Epilepsy research and treatment (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and Statistical Methods in Clinical Trials (4 papers). Daniël M. Jonker collaborates with scholars based in Denmark, Netherlands and Sweden. Daniël M. Jonker's co-authors include Mats O. Karlsson, Radojka M. Savić, Thomas Kerbusch, Meindert Danhof, Rob A. Voskuyl, Sandra A. G. Visser, R.A. Voskuyl, Peter M. Edelbroek, Geert J.F. Brekelmans and Gerrit‐Jan de Haan and has published in prestigious journals such as British Journal of Pharmacology, Pharmacology & Therapeutics and Human Reproduction.

In The Last Decade

Daniël M. Jonker

17 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniël M. Jonker Denmark 10 224 180 152 142 109 19 890
Eric Snoeck Belgium 18 176 0.8× 96 0.5× 154 1.0× 103 0.7× 100 0.9× 44 1.1k
Michael J. Fossler United States 22 371 1.7× 186 1.0× 85 0.6× 153 1.1× 123 1.1× 69 1.5k
Sang-Goo Shin South Korea 17 193 0.9× 92 0.5× 95 0.6× 91 0.6× 141 1.3× 47 752
Garth Rapeport United Kingdom 20 205 0.9× 180 1.0× 137 0.9× 134 0.9× 46 0.4× 50 1.4k
Ronald Gieschke Switzerland 21 304 1.4× 81 0.5× 157 1.0× 150 1.1× 134 1.2× 47 1.5k
Charles Locke United States 20 192 0.9× 156 0.9× 55 0.4× 163 1.1× 136 1.2× 54 1.4k
Manoranjenni Chetty United Kingdom 18 221 1.0× 179 1.0× 141 0.9× 88 0.6× 49 0.4× 41 953
Deborah Panebianco United States 22 233 1.0× 124 0.7× 206 1.4× 68 0.5× 57 0.5× 64 1.4k
Michael Steffens Germany 19 290 1.3× 98 0.5× 61 0.4× 93 0.7× 105 1.0× 60 1.1k
Miriam Saiz‐Rodríguez Spain 19 191 0.9× 176 1.0× 166 1.1× 116 0.8× 57 0.5× 58 984

Countries citing papers authored by Daniël M. Jonker

Since Specialization
Citations

This map shows the geographic impact of Daniël M. Jonker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniël M. Jonker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniël M. Jonker more than expected).

Fields of papers citing papers by Daniël M. Jonker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniël M. Jonker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniël M. Jonker. The network helps show where Daniël M. Jonker may publish in the future.

Co-authorship network of co-authors of Daniël M. Jonker

This figure shows the co-authorship network connecting the top 25 collaborators of Daniël M. Jonker. A scholar is included among the top collaborators of Daniël M. Jonker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniël M. Jonker. Daniël M. Jonker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Baker, Teresa, Ulrike Lorch, Yu Z. Bagger, et al.. (2024). No Measurable Transfer of Oxytocin-Receptor Agonist Merotocin Detected in Human Breast Milk. Breastfeeding Medicine. 19(6). 451–458.
2.
Shao, Feng, Yi Jiang, Sijia Ding, et al.. (2022). Pharmacokinetics and Safety of Follitropin Delta in Gonadotropin Down-Regulated Healthy Chinese Women. Clinical Drug Investigation. 43(1). 37–44. 7 indexed citations
3.
Jonker, Daniël M., et al.. (2021). Bounded Integer Modeling of Symptom Scales Specific to Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. The AAPS Journal. 23(2). 33–33. 1 indexed citations
5.
Jonker, Daniël M., et al.. (2021). First pre-filled pen device with highly purified human menopausal gonadotropin (HP-hMG, Menopur) in liquid is shown to be bioequivalent to powder for reconstitution. International Journal of Clinical Pharmacology and Therapeutics. 59(12). 794–803. 3 indexed citations
8.
Jonker, Daniël M., et al.. (2019). Dose Finding in the Clinical Development of 60 US Food and Drug Administration–Approved Drugs Compared With Learning vs. Confirming Recommendations. Clinical and Translational Science. 12(5). 481–489. 8 indexed citations
9.
Ingwersen, Steen H., Rajanikanth Madabushi, Estelle Watson, et al.. (2011). Dosing Rationale for Liraglutide in Type 2 Diabetes Mellitus: A Pharmacometric Assessment. The Journal of Clinical Pharmacology. 52(12). 1815–1823. 32 indexed citations
10.
Watson, Estelle, Daniël M. Jonker, Lisbeth V. Jacobsen, & Steen H. Ingwersen. (2010). Population Pharmacokinetics of Liraglutide, a Once‐Daily Human Glucagon‐Like Peptide‐1 Analog, in Healthy Volunteers and Subjects With Type 2 Diabetes, and Comparison to Twice‐Daily Exenatide. The Journal of Clinical Pharmacology. 50(8). 886–894. 43 indexed citations
11.
Savić, Radojka M., Daniël M. Jonker, Thomas Kerbusch, & Mats O. Karlsson. (2007). Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies. Journal of Pharmacokinetics and Pharmacodynamics. 34(5). 711–726. 401 indexed citations
12.
Jonker, Daniël M., Rob A. Voskuyl, & Meindert Danhof. (2007). Synergistic Combinations of Anticonvulsant Agents: What Is the Evidence from Animal Experiments?. Epilepsia. 48(3). 412–434. 43 indexed citations
13.
Jonker, Daniël M., et al.. (2005). A pharmacokinetic-pharmacodynamic model for the quantitative prediction of dofetilide clinical QT prolongation from human ether-a-go-go-related gene current inhibition data. Clinical Pharmacology & Therapeutics. 77(6). 572–582. 69 indexed citations
14.
Jonker, Daniël M., Rob A. Voskuyl, & Meindert Danhof. (2004). Pharmacodynamic Analysis of the Anticonvulsant Effects of Tiagabine and Lamotrigine in Combination in the Rat. Epilepsia. 45(5). 424–435. 18 indexed citations
15.
Jonker, Daniël M., et al.. (2004). Towards a mechanism-based analysis of pharmacodynamic drug?drug interactions in vivo. Pharmacology & Therapeutics. 106(1). 1–18. 107 indexed citations
16.
18.
Jonker, Daniël M., et al.. (2002). Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers. British Journal of Clinical Pharmacology. 53(5). 501–507. 117 indexed citations
19.
Piepponen, Petteri, et al.. (1999). Characterization of the decrease of extracellular striatal dopamine induced by intrastriatal morphine administration. British Journal of Pharmacology. 127(1). 268–274. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026